A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
about
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewBlood as a Substitute for Tumor Tissue in Detecting EGFR Mutations for Guiding EGFR TKIs Treatment of Nonsmall Cell Lung Cancer: A Systematic Review and Meta-AnalysisComparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemiaA simple, fast and inexpensive method for mutation scanning of CFTR genePanel based MALDI-TOF tumour profiling is a sensitive method for detecting mutations in clinical non small cell lung cancer tumour.Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto's ThyroiditisA comparison of ARMS and mutation specific IHC for common activating EGFR mutations analysis in small biopsy and cytology specimens of advanced non small cell lung cancer.A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryComparative evaluation of the new FDA approved THxID™-BRAF test with High Resolution Melting and Sanger sequencingSingle-Tube Mutation Scanning of The Epidermal Growth Factor Receptor Gene Using Multiplex LATE-PCR and Lights-On/Lights-Off ProbesComparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.From the bench to bedside: biological and methodology considerations for the future of companion diagnostics in nonsmall cell lung cancer.A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencingComparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancerBRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and ResistanceEpidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patientsMutation analysis of BRAF and KIT in circulating melanoma cells at the single cell level.BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.Detecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques.Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung CancerHighly sensitive and quantitative evaluation of the EGFR T790M mutation by nanofluidic digital PCR.Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodulesPatients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor.Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classificaMechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencingDetection of EGFR gene mutations in non-small cell lung cancer: lessons from a single-institution routine analysis of 1,403 tumor samplesExploring the impact of EGFR T790M neighboring SNPs on ARMS-based T790M mutation assayEGFR mutations in surgically resected fresh specimens from 697 consecutive Chinese patients with non-small cell lung cancer and their relationships with clinical features.EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.Management of tyrosine kinase inhibitor resistance in lung cancer with EGFR mutationDevelopment of a multiplex amplification refractory mutation system reverse transcription polymerase chain reaction assay for the differential diagnosis of Feline leukemia virus vaccine and wild strains.Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations.A comparison of ARMS and direct sequencing for EGFR mutation analysis and tyrosine kinase inhibitors treatment prediction in body fluid samples of non-small-cell lung cancer patients.Comparison of direct sequencing and amplification refractory mutation system for detecting epidermal growth factor receptor mutation in non-small-cell lung cancer patients: a systematic review and meta-analysisSensitive detection of BRAF V600E mutation by Amplification Refractory Mutation System (ARMS)-PCR.
P2860
Q26785713-04296D03-6F56-4BA6-8BD3-279724C8DDB3Q28087366-26CBEB18-017E-4962-8C5F-48643D938D6CQ33712307-C7018478-8100-4741-AC8C-FEF286AF16E3Q33730586-78F181D2-3E31-47C7-BD28-511A1206ACDBQ33793611-6078CC86-169D-405A-83F5-60AC4DA4604CQ33884794-8960CD0F-1C62-40E7-A740-222CB8AC5AD8Q34029261-22F6F800-24AE-4DB1-837A-26816F6F3E08Q34405695-FEFD550F-18BE-4128-BA46-C9728E6D0A03Q34469532-5D773E55-AAC8-4C09-8A92-E6574208B46DQ34523257-88C55CCC-96FD-4D8E-809E-719BA9368B5CQ34567984-47F7A9CB-0D57-4D94-941F-9D67DFCD8F17Q34633455-A8997232-5EAF-4313-8864-5C00962CD059Q34748747-906E8031-14A3-4014-9081-C19310EB91AAQ35117568-77060C3D-ED35-498E-BEDC-53F1254421F1Q35336961-63D3DFDC-3676-48FC-B5D6-EBAAD996C0BBQ35576801-97C83164-6DFF-4A26-AF0C-B54F36584B5DQ35607456-D9EFC625-D375-4B1C-8A3F-303F065639F9Q35812818-AA08DFCF-19B0-45C4-AFB0-9A21D741A161Q35835111-707F5FF2-FF88-431F-B45E-558677F60C1AQ35985808-A4A35F1A-DEFA-4F97-9079-FB5FF7013B00Q36058758-1BCBD881-9A2D-4388-81F1-B1894473297BQ36148697-116FC0CF-36C9-4927-8A13-500ED39929C6Q36299723-7788D76C-AE43-4994-ADDC-D0627BC599AAQ36310205-055AF7AF-3B43-498D-8AE6-31490606132CQ36462950-32A68F79-48D6-46A6-A727-8BA0CF4BF36EQ36872186-E6C8D7AD-8AC1-40BC-B776-1050E25A6FB4Q36942619-E6642065-189A-4A4C-B549-568E26A35AF4Q37138015-690D8657-B366-4AF6-B711-0F0E912BB5ACQ37313331-7207A889-B56F-48A7-8F89-01D2AA7D6E33Q37407368-D773D1DC-473E-4559-B846-B6E2C8830E15Q37421036-3B7EDBD9-4120-484A-8440-325A8280D9F4Q38061599-8E7C1770-D4D0-42F3-82EA-E80EBEAF2ACBQ38258749-A43ACCE5-FAFF-403A-9E40-95A92D2E1698Q38993580-0ECDB8AD-DB66-4BFE-BF24-77CB6D3B2B77Q39211838-95F3ED54-B006-41FF-9477-E357D4548399Q40476723-1E919DDF-32BF-4A6E-8A27-05B1D2D6A01AQ41331019-DF69D4BD-7058-45A8-A0A2-991466553D92Q41574578-E92C02D9-D42E-4003-A4D9-15D908523F18Q41709088-44C1F178-BADF-4402-9CB2-329C0F163D8BQ42176497-1E93768C-2D72-441D-B493-BF975D0B6E93
P2860
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
@en
type
label
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
@en
prefLabel
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
@en
P2093
P2860
P356
P1476
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
@en
P2093
Emma Donald
Gael McWalter
Georgina Speake
Gillian Ellison
Lucy Knight
Lynn Fletcher
Mireille Cantarini
P2860
P2888
P356
10.1186/1756-9966-29-132
P577
2010-10-06T00:00:00Z
P5875
P6179
1049331491